Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05421533 · ClinicalTrials.gov registry record
Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
A clinical trial, sponsored by Anthos Therapeutics.
- Terminated
- Registry status
- 705
- Enrollment target
NCT05421533 is a clinical trial that was terminated before completion, run by Anthos Therapeutics. The registered enrollment target is 705 participants.
The verdict
NCT05421533 was terminated before completion, sponsored by Anthos Therapeutics.
- TERMINATED
- Registry status
- 705 participants
- Enrollment target
Study Summary
The GARDENIA registry will collect real-world clinical data on the anticoagulant strategies in patients with AF at elevated risk of stroke but also elevated risk of bleeding.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 705 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2024-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05421533
The ClinicalTrials.gov registry entry for NCT05421533 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 705 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anthos Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05421533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05421533 about?
NCT05421533 is a clinical study titled "Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke". The GARDENIA registry will collect real-world clinical data on the anticoagulant strategies in patients with AF at elevated risk of stroke but also elevated risk of bleeding.
What is the current status of trial NCT05421533?
This trial is currently terminated. The enrollment target is 705 participants. The study started on 2022-09-14. Estimated completion is 2024-09-30.
Who is sponsoring clinical trial NCT05421533?
This trial is sponsored by Anthos Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.